Cargando…
Combined epigenetic/genetic study identified an ALS age of onset modifier
Age at onset of amyotrophic lateral sclerosis (ALS) is highly variable (eg, 27–74 years in carriers of the G(4)C(2)-expansion in C9orf72). It might be influenced by environmental and genetic factors via the modulation of DNA methylation (DNAm) at CpG-sites. Hence, we combined an epigenetic and genet...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066440/ https://www.ncbi.nlm.nih.gov/pubmed/33892821 http://dx.doi.org/10.1186/s40478-021-01183-w |
_version_ | 1783682572054691840 |
---|---|
author | Zhang, Ming Xi, Zhengrui Saez-Atienzar, Sara Chia, Ruth Moreno, Danielle Sato, Christine Montazer Haghighi, Mahdi Traynor, Bryan J. Zinman, Lorne Rogaeva, Ekaterina |
author_facet | Zhang, Ming Xi, Zhengrui Saez-Atienzar, Sara Chia, Ruth Moreno, Danielle Sato, Christine Montazer Haghighi, Mahdi Traynor, Bryan J. Zinman, Lorne Rogaeva, Ekaterina |
author_sort | Zhang, Ming |
collection | PubMed |
description | Age at onset of amyotrophic lateral sclerosis (ALS) is highly variable (eg, 27–74 years in carriers of the G(4)C(2)-expansion in C9orf72). It might be influenced by environmental and genetic factors via the modulation of DNA methylation (DNAm) at CpG-sites. Hence, we combined an epigenetic and genetic approach to test the hypothesis that some common single nucleotide polymorphisms (SNPs) at CpG-sites (CpG-SNPs) could modify ALS age of onset. Our genome-wide DNAm analysis suggested three CpG-SNPs whose DNAm levels are significantly associated with age of onset in 249 ALS patients (q < 0.05). Next, genetic analysis validated the association of rs4970944 with age of onset in the discovery (n = 469; P = 0.025) and replication (n = 4160; P = 0.007) ALS cohorts. A meta-analysis of the cohorts combined showed that the median onset in AA-carriers is two years later than in GG-carriers (n = 4629; P = 0.0012). A similar association was observed with its tagging SNPs, implicating a 16 Kb region at the 1q21.3 locus as a modifier of ALS age of onset. Notably, rs4970944 genotypes are also associated with age of onset in C9orf72-carriers (n = 333; P = 0.025), suggesting that each A-allele delays onset by 1.6 years. Analysis of Genotype-Tissue Expression data revealed that the protective A-allele is linked with the reduced expression of CTSS in cerebellum (P = 0.00018), which is a critical brain region in the distributed neural circuits subserving motor control. CTSS encodes cathepsin S protein playing a key role in antigen presentation. In conclusion, we identified a 16 Kb locus tagged by rs4970944 as a modifier of ALS age of onset. Our findings support the role of antigen presenting processes in modulating age of onset of ALS and suggest potential drug targets (eg, CTSS). Future replication studies are encouraged to validate the link between the locus tagged by rs4970944 and age of onset in independent ALS cohorts, including different ethnic groups. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01183-w. |
format | Online Article Text |
id | pubmed-8066440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80664402021-04-26 Combined epigenetic/genetic study identified an ALS age of onset modifier Zhang, Ming Xi, Zhengrui Saez-Atienzar, Sara Chia, Ruth Moreno, Danielle Sato, Christine Montazer Haghighi, Mahdi Traynor, Bryan J. Zinman, Lorne Rogaeva, Ekaterina Acta Neuropathol Commun Research Age at onset of amyotrophic lateral sclerosis (ALS) is highly variable (eg, 27–74 years in carriers of the G(4)C(2)-expansion in C9orf72). It might be influenced by environmental and genetic factors via the modulation of DNA methylation (DNAm) at CpG-sites. Hence, we combined an epigenetic and genetic approach to test the hypothesis that some common single nucleotide polymorphisms (SNPs) at CpG-sites (CpG-SNPs) could modify ALS age of onset. Our genome-wide DNAm analysis suggested three CpG-SNPs whose DNAm levels are significantly associated with age of onset in 249 ALS patients (q < 0.05). Next, genetic analysis validated the association of rs4970944 with age of onset in the discovery (n = 469; P = 0.025) and replication (n = 4160; P = 0.007) ALS cohorts. A meta-analysis of the cohorts combined showed that the median onset in AA-carriers is two years later than in GG-carriers (n = 4629; P = 0.0012). A similar association was observed with its tagging SNPs, implicating a 16 Kb region at the 1q21.3 locus as a modifier of ALS age of onset. Notably, rs4970944 genotypes are also associated with age of onset in C9orf72-carriers (n = 333; P = 0.025), suggesting that each A-allele delays onset by 1.6 years. Analysis of Genotype-Tissue Expression data revealed that the protective A-allele is linked with the reduced expression of CTSS in cerebellum (P = 0.00018), which is a critical brain region in the distributed neural circuits subserving motor control. CTSS encodes cathepsin S protein playing a key role in antigen presentation. In conclusion, we identified a 16 Kb locus tagged by rs4970944 as a modifier of ALS age of onset. Our findings support the role of antigen presenting processes in modulating age of onset of ALS and suggest potential drug targets (eg, CTSS). Future replication studies are encouraged to validate the link between the locus tagged by rs4970944 and age of onset in independent ALS cohorts, including different ethnic groups. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01183-w. BioMed Central 2021-04-23 /pmc/articles/PMC8066440/ /pubmed/33892821 http://dx.doi.org/10.1186/s40478-021-01183-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhang, Ming Xi, Zhengrui Saez-Atienzar, Sara Chia, Ruth Moreno, Danielle Sato, Christine Montazer Haghighi, Mahdi Traynor, Bryan J. Zinman, Lorne Rogaeva, Ekaterina Combined epigenetic/genetic study identified an ALS age of onset modifier |
title | Combined epigenetic/genetic study identified an ALS age of onset modifier |
title_full | Combined epigenetic/genetic study identified an ALS age of onset modifier |
title_fullStr | Combined epigenetic/genetic study identified an ALS age of onset modifier |
title_full_unstemmed | Combined epigenetic/genetic study identified an ALS age of onset modifier |
title_short | Combined epigenetic/genetic study identified an ALS age of onset modifier |
title_sort | combined epigenetic/genetic study identified an als age of onset modifier |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066440/ https://www.ncbi.nlm.nih.gov/pubmed/33892821 http://dx.doi.org/10.1186/s40478-021-01183-w |
work_keys_str_mv | AT zhangming combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT xizhengrui combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT saezatienzarsara combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT chiaruth combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT morenodanielle combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT satochristine combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT montazerhaghighimahdi combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT traynorbryanj combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT zinmanlorne combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier AT rogaevaekaterina combinedepigeneticgeneticstudyidentifiedanalsageofonsetmodifier |